SIRTain regulators of premature senescence and accelerated aging. by Zhou, Z & Ghosh, S
Title SIRTain regulators of premature senescence and acceleratedaging.
Author(s) Ghosh, S; Zhou, Z
Citation Protein & Cell, 2015, v. 6, p. 322-333
Issued Date 2015
URL http://hdl.handle.net/10722/216597
Rights Creative Commons: Attribution 3.0 Hong Kong License
REVIEW
SIRTain regulators of premature senescence
and accelerated aging
Shrestha Ghosh1, Zhongjun Zhou1,2&
1 Department of Biochemistry, The University of Hong Kong, Hong Kong, China
2 Shenzhen Institute of Innovation and Technology, The University of Hong Kong, Hong Kong, China
& Correspondence: Zhongjun@hku.hk (Z. Zhou)
Received December 17, 2014 Accepted February 28, 2015
ABSTRACT
The sirtuin proteins constitute class III histone
deacetylases (HDACs). These evolutionarily conserved
NAD+-dependent enzymes form an important compo-
nent in a variety of cellular and biological processes
with highly divergent as well as convergent roles in
maintaining metabolic homeostasis, safeguarding ge-
nomic integrity, regulating cancer metabolism and also
inﬂammatory responses. Amongst the seven known
mammalian sirtuin proteins, SIRT1 has gained much
attention due to its widely acknowledged roles in pro-
moting longevity and ameliorating age-associated
pathologies. The contributions of other sirtuins in the
ﬁeld of aging are also gradually emerging. Here, we
summarize some of the recent discoveries in sirtuins
biology which clearly implicate the functions of sirtuin
proteins in the regulation of premature cellular senes-
cence and accelerated aging. The roles of sirtuins in
various cellular processes have been extrapolated to
draw inter-linkage with anti-aging mechanisms. Also,
the latest ﬁndings on sirtuins which might have potential
effects in the process of aging have been reviewed.
KEYWORDS sirtuins, senescence, premature aging,
longevity
INTRODUCTION
The phenomenon of premature aging has intrigued re-
searchers all over the globe. Given that the primary motive of
nearly all biomedical research is to promote healthspan of
individuals or target diseases to improve health of patients,
study of the aging process and other pathologies associated
with it has ignited huge interest in dissecting the molecular
pathways contributing to this process. In this scenario, pre-
mature aging disorders in humans and the various animal
model systems recapitulating the phenotypes of accelerated
aging and cellular senescence constitute a major area of
interest in understanding the intricacies of the process of
aging. The ﬁeld of premature aging has garnered immense
interest also because of the emerging number of premature
aging disorders observed in humans, with a signiﬁcant pro-
portion of the syndromes originating from mutations in par-
ticular genes. For example, laminopathy-based premature
aging syndromes (collectively known as laminopathies) ori-
ginate from mutations in the LMNA gene or ZMPSTE24 gene
(Schreiber and Kennedy, 2013). Also, mutation or deletion of
genes involved in DNA damage repair or chromatin remod-
eling, result in premature aging phenotypes (Ghosh and
Zhou, 2014). In this regard, the silent information regulator
proteins (SIRT) or the sirtuins have displayed intricate roles
in promoting anti-aging effects via modulation of a spectrum
of biological processes ranging from genomic maintenance,
metabolic regulation, tumor suppression, inﬂammation and
others (Fig. 1) (Choi and Mostoslavsky 2014). The sirtuins
are evolutionarily conserved NAD+-dependent deacylases
and ADP-ribosyltransferases (Saunders and Verdin 2007).
In mammals, seven sirtuin proteins (SIRT1–7) have been
identiﬁed as of now with conserved central catalytic core
domains ﬂanked by differing amino and carboxyl termini,
which confer individuality to the seven sirtuins in terms of
structure, cellular localization and functioning (Saunders and
Verdin 2007). In this review, we have analyzed the varying
roles of sirtuins with implications in the process of premature
cellular senescence and accelerated aging.
SIRT1
SIRT1 is by far the most extensively studied mammalian
sirtuin. Its multifaceted roles in a spectrum of pivotal
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biological functions, such as metabolic regulation, tumor
suppression, apoptosis and other stress response signaling
pathways, and also aging processes, have brought this sir-
tuin to limelight (Giblin et al., 2014). SIRT1 has garnered
further attention by being involved in longevity expansion
and also premature aging via regulation of multiple signaling
pathways and cellular processes (Rehan et al., 2014). Some
of the recent advancements which solidify the importance of
SIRT1 in premature senescence and accelerated aging are
discussed below:
CELLULAR SENESCENCE
Mammalian SIRT1, the closest homologue of yeast sirt2
protein, has time and again been linked to premature cellular
senescence, one of the critical processes contributing to
accelerated aging. The involvement of SIRT1 in modulating
cellular senescence was identiﬁed with its deacetylation of
p53 and eventual attenuation of promyelocytic leukemia
protein (PML)-mediated premature cellular senescence
(Langley et al., 2002). Loss of SIRT1 level or activity in hu-
man umbilical vein endothelial cells (HUVECs) results in
premature senescence-associated phenotypes, such as
enhanced β-galactosidase (SA-β-gal) activity, persistent
growth arrest and also ﬂattened cellular morphology (Ota
et al., 2007). This suggests a protective role of SIRT1 in
preventing endothelial dysfunction, which is one of the re-
sulting features of cellular senescence. The role of SIRT1 as
a guardian against endothelial cellular senescence is further
bolstered by the ﬁnding that inhibition of SIRT1 expression
by miR-217 promotes cellular senescence in the endothelial
cells (Menghini et al., 2009). Upregulation of SIRT1 ex-
pression by peroxisome proliferator-activated receptor
(PPAR)δ also downregulates early senescence in an-
giotensin (Ang) II-treated human coronary artery endothelial
cells (HCAECs) (Kim et al., 2012). It is reported that hyper-
glycemia promotes premature senescence in vascular en-
dothelial cells by downregulating SIRT1 expression levels
(Mortuza et al., 2013). Further, the protective functions of
cilostazol (a selective PDE3 inhibitor) in oxidative stress-in-
duced premature senescence in endothelial cells, has been
traced back to the upregulation of SIRT1 expression (Ota
et al., 2008). On the other hand, the role of persistent insulin-
like growth factor (IGF) treatment in triggering premature
cellular senescence in a p53-dependent manner is well
known (Salvioli et al., 2009). A recent study unraveled that
this phenomenon results in attenuation of SIRT1 deacety-
lase functioning, causing enhanced p53 acetylation and
stabilization, thus bringing about premature cellular senes-
cence (Tran et al., 2014). Taken together, SIRT1 stands as a
major protector against the progression of cardiovascular
diseases which are triggered by endothelial dysfunctioning.
Apart from protecting against endothelial senescence,
SIRT1 also plays a key role in preventing stress-induced
premature senescence (SIPS) and lung inﬂammaging, one
of the hallmarks of chronic obstructive pulmonary disease
(COPD) or emphysema (Yao et al., 2012). The levels of
SIRT1 expression and activity are signiﬁcantly reduced in
the lungs of COPD patients. In addition, enhancement of
SIRT1 expression or activity inhibits stress-induced prema-
ture cellular senescence and also provides protection
against cigarette smoke-induced emphysema (Yao et al.,
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Figure 1. Schematic representation showing the regulation of premature aging by sirtuins via multiple biological processes.
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2012). This SIRT1-mediated protection against emphysema
is reported to be catalyzed by FOXO3 transcription factor
(Yao et al., 2012).
REPLICATIVE SENESCENCE
Replicative senescence is brought about in primary cells
because of telomere shortening after every round of cell
cycle, which signals the cells of stress and limits the number
of cell divisions. Expression level of SIRT1 is reported to
decrease as the primary human ﬁbroblasts enter replicative
senescence phase (Michishita et al., 2005). Additionally,
SIRT1 overexpression is reported to attenuate oncogene-
induced replicative senescence via p53 deacetylation
(Langley et al., 2002). However, upon prolonged cell repli-
cation in culture, primary Sirt1-/- mouse embryonic ﬁbroblasts
(MEFs) display resistance towards replicative senescence
(Chua et al., 2005). Nevertheless, SIRT1 knockdown in hu-
man diploid ﬁbroblasts has been reported to induce cell
proliferation (Abdelmohsen et al., 2007). The contribution of
SIRT1 in promoting replicative senescence can be further
gauged from the ﬁnding that it deacetylates histone H1 on
lysine 26 (K26), and also histone H4 at K16 and H3 on K9, to
endorse facultative heterochromatin formation (Vaquero
et al., 2004). It is widely known that loss of heterochromatin
is one of the hallmarks for premature cellular senescence
and accelerated aging (Shumaker et al., 2006). Hence, given
the progressive decline in SIRT1 level with passage, it is
plausible that these histone marks get hyperacetylated to
further lead to heterochromatin loss, thus resulting in even-
tual replicative senescence. Moreover, SIRT1 is reported to
deacetylate WRN, the protein mutated in Werner syndrome
causing telomere attrition (Li et al., 2008). Taken together,
SIRT1 plays a key role in blocking replicative senescence
via regulation of multiple proteins.
MAINTENANCE OF ‘STEMNESS’
SIRT1 expression levels have been reported to be higher in
mouse embryonic stem cells (mESCs) as compared to the
differentiated cells (Saunders et al., 2010). This phe-
nomenon has been attributed to post-transcriptional down-
regulation of SIRT1 by a range of miRNAs, such as miR-9,
miR-181a and b, and others (Saunders et al., 2010). Inter-
estingly, the authors also reported an induction in SIRT1
protein levels when the MEFs were reprogrammed into in-
duced pluripotent stem (iPS) cells. Recently, SIRT1 has
been implicated in the maintenance of mESCs self-renewal
by being directly regulated viamiR-29b in response to reac-
tive oxygen species (ROS) (Xu et al., 2014). In addition,
SIRT1 has been reported to be involved in the maintenance
of haematopoietic stem cells (HSCs) homeostasis and lin-
eage speciﬁcation, where loss of SIRT1 in HSCs garnered
DNA damage, accumulation of age-linked molecules and
other phenotypes of aging HSCs (Rimmelé et al. 2014).
Intriguingly, overexpression of SIRT1 or its activation by
resveratrol is reported to rescue senescence-associated
phenotypes and also angiogenic defects in preterm-en-
dothelial colony forming progenitor cells (PT-ECFCs) (Vas-
sallo et al., 2014). To add to this, overexpression of SIRT1
also delays senescence in the bone marrow-derived mes-
enchymal stem cells (B-MSCs) (Yuan et al., 2012). Further,
cleavage of SIRT1 by cathepsin triggers stress-induced
premature senescence (SIPS) in endothelial progenitor cells
(Chen et al., 2012). On the whole, SIRT1 stands out as a
prominent housekeeper of maintaining stemness by resist-
ing senescence in the cells.
DNA DAMAGE REPAIR AND AGING
Impaired DNA damage repair and accrued genomic insta-
bility are some of the chief factors contributing to premature
cellular senescence and accelerated aging (Liu et al., 2005).
In this arena, SIRT1 is reported to induce DNA damage re-
pair by deacetylating the repair protein Ku70 upon irra-
diation-induced DNA damage (Jeong et al., 2007). The
association of RNA-binding protein HuR, SIRT1 and NBS1 in
the maintenance of genomic integrity upon genotoxic stress
is also extensively studied (Gorospe and de Cabo, 2008).
SIRT1 has been linked in safeguarding against DNA dam-
age and atherosclerosis in human vascular smooth muscle
cells (VSMCs) by activating the repair protein Nijmegen
breakage syndrome-1 (NBS-1), but not p53 (Gorenne et al.,
2013). SIRT1 is also widely acknowledged to deacetylate
PARP1, a key player in DNA damage repair and aging, and
thus mediate response signaling upon genotoxic stress
(Rajamohan et al., 2009). The intricate inter-linkage between
SIRT1 and PARP1 has been time and again established to
play crucial roles in genotoxic stress and DNA damage re-
sponses (Luna et al., 2013) The involvement of SIRT1 in
DNA damage repair has been further solidiﬁed by the ﬁnding
that it activates homologous recombination (HR) repair in
human cells (Uhl et al., 2010). However, the authors refuted
the involvement of Ku70, PARP1 or NBS1 in SIRT1-medi-
ated repair, and advocated the role of WRN protein in this
process. This suggests that SIRT1 possibly mediates dif-
ferent repair pathways via modulation of repair proteins in a
mutually exclusive way. On the other hand, overexpression
of SIRT1 has been reported to negatively regulate Tip60-
mediated acetylation of H2AX, an event ﬁnely regulated to
elicit proper DNA damage response (Yamagata and Kita-
bayashi, 2009). Thus, SIRT1 possibly represses extensive
DNA damage response to ﬁne-tune HR repair process by
repressing H2AX over-activation. Recently, SIRT1 has been
reported to display prompt recruitment to double strand
breaks (DSBs) in post-mitotic neurons, where it deacetylates
HDAC1 and stimulates ATM autophosphorylation to mediate
non-homologous end joining (NHEJ) repair (Dobbin et al.,
2013). Thus, SIRT1 plays a protective role in maintaining
genomic integrity not only against genotoxic stress but also
to attenuate neurodegeneration.
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LIFESPAN EXTENSION
SIR2 was the ﬁrst identiﬁed evolutionarily conserved gene
which had been implicated in the expansion of lifespan. At-
tention was drawn towards the sirtuins when sir2 inactivation
in yeasts reduced lifespan by 50%, while introduction of an
extra copy of the gene SIR2 increased yeast lifespan by 30%
(Kaeberlein et al., 1999). This ﬁnding has been contradicted
by an independent research group which failed to replicate
longevity expansion in yeast or drosophila by sir2 overex-
pression (Burnett et al., 2011). However, another group could
successfully extend longevity in C. elegans by sir-2.1 over-
expression, attributing this occurrence to nicotinamide (NAM)
methylation (Schmeisser et al., 2013). Apart from these re-
ports,Sirt1 transgenic mice did not exhibit any overall lifespan
extension (Herranz et al., 2010). However, SIRT1 overex-
pression in those mice displayed improvement of some age-
associated phenotypes, such as wound healing, decreased
tumorigenicity, better maintenance of glucose homeostasis
and others. Intriguingly, SIRT1 overexpression speciﬁcally in
brain increases longevity by approximately 11% in both male
and femalemice, and also reduces incidence of cancer (Satoh
et al., 2013). This phenomenon has been largely attributed to
SIRT1-mediated upregulation of Orexin type-2 receptor
(Ox2r) expression speciﬁcally in the nuclei of dorsomedial and
lateral hypothalamic (DMH and LH) regions of brain. In addi-
tion, this organ-speciﬁc SIRT1 activation can be explained by
the observation that NK2 homeobox 1 (Nkx2-1) speciﬁcally
colocalizes with SIRT1 in the DMH and LH regions of brain to
upregulate Ox2r expression and thus increase longevity.
Hence, this study further reinstated the importance of SIRT1 in
delaying senescence and premature aging. Nevertheless,
loss of sirt1 in mice resulted in severe growth defects causing
death of litters in the late prenatal or early postnatal stages,
thus implying SIRT1’s major contribution in development
(Cheng et al., 2003). Given the involvement of SIRT1 in
deacetylating anddeactivating p53, theauthors also observed
that p53 was hyperacetylated upon DNA damage in Sirt1-/-
mice tissues (Cheng et al., 2003). However, mice deﬁcient for
both sirt1 andp53neither displayedany signiﬁcant differences
from Sirt1-/- mice, nor any amelioration in the growth and de-
velopmental defects (Kamel et al., 2006), thus suggesting that
the impairments observed in Sirt1-/- mice are not majorly at-
tributable to p53 activation. Recently, SIRT1 activation has
been linked to amelioration of skeletal muscle performance in
sarcopenia or atrophy during aging, mainly via inhibition of
PARP1 (Mohamedet al., 2014). Taken together, SIRT1 can be
regarded as a prominent, although much debated, player in
promoting longevity and attenuating premature aging.
INVOLVEMENT IN LAMINOPATHY-BASED
PREMATURE AGING
Animal models of laminopathy-based premature aging pro-
vide excellent model systems for studying the process of
accelerated aging and cellular senescence. Although rare,
some of the disease phenotypes are highly severe with ir-
reparable mortality in patients in their early teens, such as in
Hutchinson-Gilford Progeria Syndrome (HGPS) (Schreiber
and Kennedy, 2013). Loss of ZMPSTE24, the metallopro-
teinase responsible for cleaving the precursor prelamin A
into mature lamin A, reiterates progeroid phenotypes in mice
(Navarro et al., 2004). Our recent work has further estab-
lished the role of SIRT1 in delaying premature cellular se-
nescence and aging by being involved in laminopathy-based
premature aging (Liu et al., 2012). We reported that lamin A,
a nuclear lamina protein, interacts with SIRT1 and also ac-
tivates it (Liu et al., 2012). This interaction is further induced
by resveratrol, thus resulting in ultimate activation of the
sirtuin protein. Our study provided a mechanistic explanation
to the long debated question of whether or not resveratrol
aids in SIRT1 activation (Kulkarni and Cantó 2014). We also
observed a prominent decline of adult stem cells (ASCs) in
the tissues derived from Zmpste24-/- mice, which was pri-
marily attributable to the dissociation of SIRT1 from nuclear
matrix in the presence of prelamin A or progerin (the pre-
cursor and mutant forms of lamin A respectively). Interest-
ingly, treatment with resveratrol not only rescued ASC
attrition, but also extended lifespan in the mutant mice along
with reduction of body weight loss and improvement in bone
mineral density. This study also reinforced the role played by
SIRT1 in the maintenance of stem cells. However, it remains
to be seen whether SIRT1 also plays signiﬁcant roles in
delaying senescence or increasing lifespan in other models
of laminopathy-based premature aging.
DIVERSE ROLES IN OTHER DISEASES
There are multiple disorders which majorly contribute to the
occurrence of premature aging, such as metabolic dys-
regulation, neurodegenerative diseases, inﬂammation and
also tumorigenesis (Giblin et al., 2014). SIRT1 has been
ascribed multifaceted roles in the regulation of proper
metabolic homeostasis by maintaining lipogenesis, gluco-
neogenesis, fatty acid oxidation and others (Chang and
Guarente, 2014). Caloric restriction-mediated lifespan ex-
tension is also largely attributed to SIRT1 (Chen and Guar-
ente, 2007). So far neurodegenerative disorders are
concerned, SIRT1 has been reported to deacetylate tau, the
protein causing Alzheimer’s disease upon pathogenic ag-
gregation, and trigger its degradation via ubiquitin (Min et al.,
2010). Also, overexpression of SIRT1 is reported to inhibit
accumulation of α-synuclein, whose pathogenic aggregation
in neurons causes Parkinson’s disease, and thus leads to
longevity (Donmez et al., 2012). Recently, diminished SIRT1
activity has been attributed to be one of the chief reasons for
causing Cockayne syndrome, a premature aging disorder
characterized by severe neurodegeneration (Scheibye-
knudsen et al., 2014). SIRT1 has also been intricately linked
to lung inﬂammaging where it is reported to play signiﬁcant
Sirtuins in premature aging REVIEW
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anti-aging roles (Yao et al., 2012). However, in regard to
cancer, SIRT1 plays both tumor suppressive and oncogenic
roles (Yuan et al., 2013).
The immense importance of SIRT1 in the process of anti-
aging can be further ascertained from the implementation of
multiple small molecule drugs which primarily act as SIRT1
activators (Hubbard and Sinclair, 2014). On the whole,
SIRT1 can be regarded as a crucial anti-aging protein which
mediates its widespread effects in preventing premature
senescence and accelerated aging by regulating multiple
molecular pathways.
SIRT2
SIRT2 is the second mammalian sirtuin protein which is
emerging out as a potential target in preventing age-related
disorders. Its possible involvement in the process of aging
and longevity can be fathomed from the observation that
expression level of SIRT2 was found upregulated in kidney
and white-adipose tissues of caloric-restricted mice (Zhu
et al., 2012). However, it remains to be seen whether caloric-
restriction fails to extend lifespan in mice lacking Sirt2. This
will provide direct evidence of the involvement of SIRT2 in
this dietary intervention-mediated lifespan extension. SIRT2
was initially identiﬁed to deacetylate α-tubulin at lysine 40
and histone H4 at lysine 16 (de Oliveira et al. 2012). Apart
from these, SIRT2 is also known to deacetylate forkhead
transcription factors of class O, namely FOXO1 and FOXO3
(Wang and Tong, 2009, Wang et al., 2007). Given the widely
acknowledged functions of FOXO transcription factors in a
spectrum of pathways directly or indirectly linked to aging,
such as metabolic regulation, DNA damage repair, apoptosis
and others, it is tempting to speculate that SIRT2 may play
an intricate role in anti-aging processes. Moreover, an in-
creasing proportion of evidence suggests tumor-suppressive
functions of SIRT2 (de Oliveira et al. 2012). Since increasing
incidence of cancer is associated with progressive aging,
SIRT2 can be considered as a potential anti-aging protein.
However, further experimentation is required to conﬁrm this
model. Recently, SIRT2 has been implicated in the sup-
pression of glioma formation (Li et al., 2013). In this study,
the authors identiﬁed p65 (a subunit of NF-ĸB signaling) as a
target of deacetylation by SIRT2 at lysine 310, thereby in-
hibiting miR-21 transcription via blockage of p65 binding with
its promoter region. This report further supported the role of
SIRT2 in tumor suppression and opened up new avenues for
the involvement of SIRT2 in premature aging via regulation
of NF-ĸB signaling. Additionally, SIRT2 overexpression in
BubR1 mice, which harbour hypomorphism for BubR1 and
display premature aging phenotypes, has been reported to
extend lifespan in the mutant mice (North et al., 2014). Given
the many implications of Wnt signaling in tumorigenesis and
aging, SIRT2-mediated attenuation of Wnt signaling pathway
upon oxidative stress (Nguyen et al., 2014), further insin-
uates at the involvement of this sirtuin in the regulation of
aging via multiple mechanisms. Apart from these, SIRT2 is
also ascribed signiﬁcant roles in safeguarding against neu-
rodegenerative disorders, such as Parkinson’s and Hunt-
ington’s diseases (de Oliveira et al., 2012). Thus, SIRT2 can
be considered as a promising target in designing intervention
against premature aging.
SIRT3
SIRT3, predominantly located in mitochondria, has been
primarily linked to the regulation of a variety of mitochondrial
processes, such as β-oxidation, ATP generation, manage-
ment of reactive oxygen species (ROS) and others (Giblin
et al., 2014). However, its roles in aging-associated disor-
ders have begun emerging in the recent years. Although
Sirt3-knockout mice do not exhibit any severe signs of pre-
mature aging or tumorigenesis, the mutant mice do display
glucose intolerance, dysregulated ROS production, and
heightened white adipose tissue (WAT) development (Jing
et al., 2011). Since ROS-induced oxidative stress is one of
the critical contributors of premature cellular senescence, it
is possible that SIRT3 might have a hand in regulating this
process. SIRT3 can be strongly associated with the main-
tenance of metabolic regulation based on the ﬁnding that
loss of Sirt3 in the germline of mice leads to accelerated
development of obesity, hepatic steatosis and insulin resis-
tance upon high-fat diet (HFD) feeding (Hirschey et al.,
2011). This study also identiﬁed reduction in Sirt3 expression
level when mice were fed with high-fat diet. Recently, SIRT3
has been implicated in the maintenance of regenerative
capacity in the haematopoietic stem cells with progressive
age (Brown et al., 2013). Haematopoietic stem cells display
high expression levels of SIRT3, where this sirtuin regulates
mitochondrial protein acetylation proﬁles and blocks oxida-
tive stress generation. This groundbreaking discovery not
only recognized the signiﬁcant roles of SIRT3 in maintaining
stemness, but also laid out a path for further dissecting its
roles in stem cell-based intervention for metabolic disorders
resulting in premature aging. In addition, some single nu-
cleotide polymorphisms (SNPs) in Sirt3 gene have been
attributed in the extension of longevity (Giblin et al., 2014).
Also, several lines of evidence suggest modulating roles for
SIRT3 in response to caloric-restriction (Kincaid and Bossy-
Wetzel 2013). Apart from these, a recent study elucidated
the involvement of SIRT3 in protection against neurode-
generation in Huntington’s disease (Fu et al., 2012). The
study identiﬁed reduced expression of SIRT3 because of
mutant protein huntingtin (Htt), which causes Huntington’s
disease. Treatment with viniferin, a naturally occurring
compound, ameliorated the disease phenotypes by en-
hancing SIRT3 expression level (Fu et al., 2012). Taken to-
gether, these studies clearly reinstate the importance of
SIRT3 in the maintenance of metabolic regulation, regen-
eration in stem cells, and also neuroprotection, all of which
contribute directly or indirectly in the acceleration of aging in
individuals when dysregulated.
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SIRT4
SIRT4 is the second mitochondrial sirtuin protein, with no
reported deacetylase activity (Saunders and Verdin 2007).
However, this sirtuin possesses ADP-ribosyltransferase ac-
tivity towards glutamate dehydrogenase (GDH) (Haigis et al.,
2006). This study also identiﬁed reduction in SIRT4 level
upon caloric-restriction, thus suggesting that SIRT4 might
antagonize this dietary restriction-mediated effect, unlike
SIRT1 and SIRT3. Further, SIRT4 has been implicated in
regulating lipid metabolism by attenuating peroxisome pro-
liferator-activated receptor α (PPARα) and thus repress rates
of fatty acid oxidation in the hepatocytes (Laurent et al.,
2013). SIRT4 has been recently identiﬁed to maintain mito-
chondrial ATP homeostasis (Ho et al., 2013). Although, there
has been no direct evidence relating SIRT4 activities with the
aging process, the involvement of this sirtuin in mitochondrial
biogenesis and ATP production insinuate at a faint possibility
that SIRT4 might be linked to the process of aging.
SIRT5
SIRT5 is the third mitochondrial sirtuin protein with very few
substrates identiﬁed till date. It was ﬁrst identiﬁed to
deacetylate carbamoyl phosphate synthetase 1 (CPS1) and
thus regulate the urea cycle (Nakagawa and Guarente
2009). It has been assumed that SIRT5 might also play a
role in mitochondrial metabolism in response to varying nu-
tritional states (Shih and Donmez, 2013). Lately, SIRT5 has
been conﬁded signiﬁcant desuccinylase activity in mito-
chondria (Rardin et al., 2013), implicating the role for SIRT5
in the repression of ketogenesis by desuccinylation of the
rate-limiting enzyme 3-hydroxy-3-methylglutaryl-CoA syn-
thase 2 (HMGCS2). Since mitochondrial dysregulation plays
a key role in bringing about senescence phenotypes, it is not
impossible that SIRT5 might play a regulatory role in the
process. Furthermore, polymorphisms in the promoter region
of SIRT5 gene have been associated with the development
of premature aging in amygdala region of brain (Glorioso
et al., 2011), suggesting the possible involvement of SIRT5
promoter polymorphisms in the incidence of Parkinson’s
disease. Further studies are required in order to clearly dif-
ferentiate roles (if any) of this sirtuin in the process of ac-
celerated aging.
SIRT6
SIRT6 is predominantly a nuclear protein, whose association
with chromatin has time and again been established (Kugel
and Mostoslavsky 2012). SIRT6 was primarily identiﬁed as a
histone deacetylase with speciﬁcity towards histone H3 at
lysine 9 and 56 (K9 and K56) (Michishita et al., 2008,
Michishita et al., 2009). This sirtuin gained prominence when
its knockout mouse model developed severe premature
aging phenotypes with mortality resulting within a month
(Mostoslavsky et al., 2006). Moreover, SIRT6 is the only
mammalian sirtuin which displayed clear increase in lifespan
when overexpressed in the whole body of mice (Kanﬁ et al.,
2012). Intriguingly, this longevity extension has only been
observed in male mice, and the underlying mechanism of
this gender-speciﬁcity is still under debate. SIRT6 can be
regarded as an important anti-aging protein with multifaceted
roles in DNA damage repair, metabolic regulation, inﬂam-
mation and also tumor suppression, as discussed below in
details.
MAINTENANCE OF GENOMIC STABILITY
The premature aging phenotypes observed in the Sirt6-/-
mice were primarily attributed to the defects observed in
base excision repair (BER) machinery (Mostoslavsky et al.,
2006). This seminal ﬁnding ignited interest in the scientiﬁc
community and multiple roles of SIRT6 in DNA damage re-
sponse began to be deciphered gradually. For example,
SIRT6 is identiﬁed to deacetylate CtIP, a DNA end resection
protein, and mediate homologous recombination (HR) repair
(Kaidi et al., 2010). SIRT6 also mono ADP-ribosylates
PARP1 in response to oxidative stress and thus promotes
non-homologous end-joining (NHEJ) repair process (Mao
et al., 2011). In addition, SIRT6 is one of the prompt recruits
to DNA double strand break (DSB) sites, and further helps in
the localization of other repair proteins like DNA-PKcs,
SNF2H and others (McCord et al., 2009, Toiber et al., 2013).
SIRT6 was also observed to progressively decline with
passage in human ﬁbroblasts (Mao et al., 2012). In addition,
overexpression of this sirtuin alleviated the repression of HR
repair observed during replicative senescence. SIRT6 has
been also reported to localize in telomeric chromatin where it
deacetylates histone H3 at K9, thus stabilizing the interaction
of WRN protein and maintaining proper telomeric metabo-
lism (Michishita et al., 2008). Since impairment in DNA
damage repair and telomere shortening are some of the
hallmarks of premature cellular senescence and are critical
contributing factors for accelerated aging, SIRT6 can be
considered as a pivotal player in DNA damage repair-me-
diated anti-aging process.
METABOLIC HOMEOSTASIS
SIRT6 is a major regulator of the maintenance of glucose
homeostasis. It has been reported to repress gluconeoge-
nesis in hepatocytes by regulating GCN5-PGC1α pathway,
thus preventing diabetic hyperglycemia (Dominy et al.,
2012). SIRT6 acts as a co-repressor of the transcription
factor Hif1α (which is involved in sensing nutritional state of
cells) and also deacetylates H3K9 at the promoters of sev-
eral glycolytic genes (Zhong et al., 2010). This provides a
mechanistic explanation to the lethal hypoglycemia ob-
served in Sirt6-/- mice. SIRT6 has been also related in
regulation of lipogenesis by repression of lipogenic tran-
scription factors, SREBP1 and SREBP2 via multiple
mechanisms (Elhanati et al., 2013). This study identiﬁed
Sirtuins in premature aging REVIEW
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reduced levels of low-density lipoprotein cholesterol in the
Sirt6 transgenic mice, thus providing another mechanistic
explanation to the increased longevity in the mutant mice.
The involvement of SIRT6 in fat metabolism is further bol-
stered by the ﬁnding that loss of this sirtuin in the liver of
mice results in formation of fatty liver due to upregulated
glycolysis and triglyceride synthesis (Kim et al., 2010).
SIRT6 is also linked in attenuating insulin-like growth factor
(IGF)-AKTsignaling and thus preventing cardiac hypertrophy
(Sundaresan et al., 2012). On the whole, SIRT6 is a critical
housekeeper of metabolic homeostasis, the imbalance of
which eventually results in premature aging phenotypes.
TUMOR SUPPRESSION
SIRT6 has been identiﬁed as a vital tumor suppressor which
critically regulates cancer metabolism (Sebastián et al.
2012). This study also identiﬁed downregulation of SIRT6 in
several forms of human cancer, such as pancreatic and col-
orectal cancer. Moreover, overexpression of SIRT6 in non-
small cell lung cancer (NSCLC) cells radiosensitizes them
which inhibits their proliferation, further supporting the idea of
SIRT6 being a tumor suppressor (Cai et al., 2014). However,
this concept has been contradicted by an independent re-
search group which reported that depletion of SIRT6 in
mouse skin inhibits tumorigenesis (Ming et al., 2014). This is
suggestive of particular cancer cell-type speciﬁc activities of
SIRT6. Nevertheless, the ﬁnding that overexpression of
SIRT6 triggers heightened apoptotic response speciﬁcally in
cancerous cells but not in normal cells (Van Meter et al.,
2011), further reinstates the role of this sirtuin as a potent
tumor suppressor. Also, degradation of SIRT6 by MDM2 has
been observed in multiple lines of breast cancer cells
(Thirumurthi et al., 2014). All these ﬁndings solidify the con-
cept of SIRT6 being a key tumor suppressor, and further
strengthen its role in delaying aging, since cancer incidence
and progressive aging go hand in hand.
INFLAMMATION
In some recent reports, SIRT6 has been identiﬁed to possess
anti-inﬂammatory functions. For example, loss of SIRT6 in
human umbilical vein endothelial cells (HUVECs) induced
proinﬂammatory cytokine expression, such as interleukin 6
(IL-6), IL-8 and also IL-1β (Lappas, 2012). Moreover, over-
expression of SIRT6 in human rheumatoid arthritis ﬁbroblast-
like cells and also in mice with collagen-induced arthritis at-
tenuated proinﬂammatory cytokine levels (Lee et al., 2013).
Given the huge implications of NF-ĸB in inﬂammatory re-
sponses, the ﬁnding that SIRT6 attenuates NF-ĸB signaling
by deacetylating histone H3 at K9 on the promoters of NF-ĸB
target genes (Kawahara et al., 2009), further establishes the
role of SIRT6 as a critical anti-inﬂammatory protein. Also, loss
of Sirt6 in immune cells derived from mice display chronic
liver inﬂammation and ﬁbrosis (Xiao et al., 2012). However,
another study has advocated that SIRT6 induces the secre-
tion of cytokines and might possibly be involved in pro-
inﬂammatory responses (Bauer et al., 2012). Since inﬂam-
matory responses have been linked to the development of
premature aging phenotypes, the role of SIRT6 in repressing
age-associated pathologies get strengthened more and
more.
Taken together, SIRT6 stands out as a key modulator of
anti-aging processes which mediates its regulatory roles via
multiple pathways to delay cellular senescence and accel-
erated aging. Hence, identiﬁcation of SIRT6 activators can
have huge therapeutic impact in designing intervention for
premature aging disorders and other age-associated
pathologies.
SIRT7
SIRT7 is the seventh mammalian sirtuin protein pre-
dominantly localized in the nucleolus with an established role
in rDNA transcription activation (Kim and Kim, 2013). In-
creasing evidences are surfacing regarding the functioning
of this sirtuin which are gradually hinting its potential role in
premature aging. Inactivation of the Sirt7 gene in mice re-
sults in lifespan reduction and the mutant mice also develop
cardiac hypertrophy and inﬂammatory cardiomyopathy
(Vakhrusheva et al. 2008a, b). These phenotypic outcomes
have been primarily attributed to lack of Sirt7-mediated p53
deacetylation in the mutant mice, thus resulting in p53 hy-
peractivation and apoptosis. However, no direct evidence
has been provided by the authors at this end regarding
in vivo Western blotting or exact sites of p53 deacetylation
by SIRT7. Thus, further experiments need to be performed in
order to draw a clear picture. Nevertheless, SIRT7 has been
ascribed an anti-proliferative role since its overexpression
ceases tumorigenicity in several lines of murine cells
(Vakhrusheva et al. 2008a). In contrast to this observation,
SIRT7 has been characterized as an oncogene which se-
lectively deacetylates histone H3 at lysine 18 to maintain
tumorigenic potential in cancer cells (Paredes et al., 2014).
Also, SIRT7 expression level is found heightened in a large
number of patients with human hepatocellular carcinoma
(HCC), and knockdown of SIRT7 repressed growth in liver
cancer cells (Kim et al., 2013). Apart from the recognition of
being an oncogene, SIRT7 is also implicated in the aging
process since its expression levels were observed to be
reduced in senescent cells (Lee et al., 2014). Moreover, the
involvement of SIRT7 in attenuation of ER stress and pre-
vention of fatty liver disease formation (Shin et al., 2013),
further extend its roles in maintenance of metabolic regula-
tion. SIRT7 is also observed to regulate lipid metabolism in
the liver (Yoshizawa et al., 2014). On the whole, it would not
be inappropriate to speculate potential roles of SIRT7 in
maintaining metabolic homeostasis, cancer metabolism, and
thus anti-aging process.
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CONCLUSION
Till date, substantial number of evidences has laid founda-
tion to the concept of sirtuins being potent anti-aging pro-
teins. Their multivalent roles in delaying cellular senescence
and blocking the development of premature aging pheno-
types further mark them as promising targets to design in-
tervention for several age-associated pathologies (Table 1).
SIRT1, being the most extensively experimented sirtuin with
regards to aging and longevity, has triggered interest in
scientiﬁc communities to develop small molecule activators
or drugs in amelioration of a wide range of aging disorders.
Several such activators and drugs for SIRT1 activation are
also commercially available for testing in labs (Mellini et al.,
2014). For example, the anti-aging effects of resveratrol are
primarily attributed to SIRT1 activation. With the emerging
reports on potential anti-aging effects of the other sirtuins,
speciﬁcally SIRT6, it would be important to screen out the
activators or modulators of these sirtuins and design drugs to
test their effects in the animal models of premature aging.
Identiﬁcation of such potent drugs to stimulate sirtuin func-
tioning can prove to be breakthroughs in ameliorating age-
associated disorders. Although development of such small
molecule activators of sirtuins or drugs and their inclusion in
clinical trials is a long-shot process, the increasing number of
ﬁndings elaborating the various sirtuins-mediated anti-aging
mechanisms, abridge the path.In conclusion, the SIRT
proteins can certainly be regarded as essential factors in
delaying cellular senescence, repressing premature aging
and enhancing longevity and healthspan in the living
systems.
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